Ditchcarbon
  • Customers
  1. Organizations
  2. Cardax, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 6 months ago

Cardax, Inc.

Company website

Cardax, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates across various regions. Founded in 2010, the company has made significant strides in developing innovative health solutions, particularly in the field of dietary supplements and pharmaceuticals. Specialising in the research and development of astaxanthin-based products, Cardax offers unique formulations that harness the antioxidant properties of this powerful carotenoid. Their flagship product, Zanthin®, stands out for its potential health benefits, including anti-inflammatory and neuroprotective effects. With a commitment to scientific excellence, Cardax has positioned itself as a leader in the nutraceutical market, achieving notable milestones in product development and regulatory approvals. The company continues to advance its mission of improving health outcomes through cutting-edge research and high-quality products.

DitchCarbon Score

How does Cardax, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Cardax, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Cardax, Inc.'s reported carbon emissions

Cardax, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Cardax, Inc. may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As such, the company does not inherit any emissions data or targets from a parent organisation, nor does it participate in recognised climate frameworks like the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). Without specific emissions data or commitments, Cardax, Inc.'s climate impact remains unclear within the industry context.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cardax, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Cardax, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Cardax, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 11 hours ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Amarin Corporation plc

IE
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Takeda

JP
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
dev
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy